TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILISATION (HCRU) IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) IN CANADA AND EUROPE

被引：0
|
作者：
Jaffe, D. H. [1 ]
Gill, S. [2 ]
DeCongelio, M. [3 ]
Dubell, A. [2 ]
Stetson, J. [2 ]
Wisniewski, T. [4 ]
Thompson, G. J. [5 ]
机构：
[1] Kantar Hlth, Tel Aviv, Israel
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] Kantar Hlth, New York, NY USA
[4] Bristol Myers Squibb, Princeton, NJ USA
[5] Bristol Myers Squibb, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.304
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN222
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [1] HEALTHCARE RESOURCE UTILISATION (HCRU) ASSOCIATED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLISATION (TACE) TREATMENT IN INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC) PATIENTS IN EUROPE
    Bailey, T.
    Thompson, G.
    Taylor-Stokes, G.
    Ghale, A.
    Begic, D.
    Bennai, Y.
    Wisniewski, T.
    [J]. VALUE IN HEALTH, 2019, 22 : S537 - S537
  • [2] PHYSICIAN ATTITUDES AND TREATMENT PATTERNS IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) IN CANADA AND EUROPE
    Gill, S.
    Jaffe, D.
    DeCongelio, M.
    Dubell, A.
    Wisniewski, T.
    Thompson, G. J.
    [J]. VALUE IN HEALTH, 2019, 22 : S97 - S97
  • [3] TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HCRU) IN ADVANCED SQUAMOUS ESOPHAGEAL CARCINOMA CANCER IN NORTH AMERICA, EUROPE AND ASIA
    Jaffe, D.
    DeCongelio, M.
    Dubell, A.
    Stetson, J.
    Gricar, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S87 - S88
  • [4] Real-World Treatment Patterns, Clinical Outcomes, Healthcare Resource Utilization, and Costs in Advanced Hepatocellular Carcinoma in Ontario, Canada
    Seung, Soo Jin
    Saherawala, Hasnain
    Kim, YongJin
    Tieu, Jimmy
    Wang, Sharon
    Shephard, Cal
    Bosse, Dominick
    [J]. CANCERS, 2024, 16 (12)
  • [5] Treatment patterns and healthcare resource utilisation (HCRU) among patients with psoriatic disease in a large national claims database
    Hsu, Ming-Ann
    Harnett, James
    Emir, Birol
    Mallbris, Lotus
    Ports, William
    Mamolo, Carla
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S22 - S22
  • [6] CONTEMPORARY MANAGEMENT OF ADVANCED HEPATOCELLULAR CARCINOMA (HCC): TREATMENT PATTERNS AMONG HEALTHCARE PROVIDERS (HCPs) AND CONCORDANCE WITH EXPERT RECOMMENDATIONS
    Topping, Ryan
    Quill, Timothy A.
    Abrams, Thomas A.
    Singal, Amit G.
    Yarchoan, Mark
    Zhu, Andrew X.
    Finn, Richard
    [J]. HEPATOLOGY, 2021, 74 : 627A - 627A
  • [7] Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
    Kim, Kyung
    Jha, Reena
    Prins, Petra A.
    Wang, Hongkun
    Chacha, Monica
    Hartley, Marion L.
    He, Aiwu Ruth
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (05) : 945 - 954
  • [8] Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment
    Kyung Kim
    Reena Jha
    Petra A. Prins
    Hongkun Wang
    Monica Chacha
    Marion L. Hartley
    Aiwu Ruth He
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 80 : 945 - 954
  • [9] US treatment patterns and healthcare resource use (HCRU) for stage IVC squamous cell carcinoma of the head and neck (SCCHN).
    Gilden, Daniel Mordecai
    Kubisiak, Joanna M.
    Chace, Meredith J.
    Bowman, Lee
    Smyth, Emily Nash
    Li, Li
    Kubisiak, Emily
    Gilden, David Ethan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND HEALTHCARE COSTS (HCC) OF PATIENTS WITH SMALL-CELL LUNG CANCER (SCLC) IN THE US
    Suri, G.
    Aslam, S.
    Takundwa, R.
    Giannopoulou, M.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S149 - S149
12345